NCT06806943 is a NA clinical trial of avatar-based interactions in Substance Use Disorder (SUD), sponsored by Le.L.A.T. Lega Lotta Aids E Tossicodipendenza.

Who is sponsoring NCT06806943?

NCT06806943 is sponsored by Le.L.A.T. Lega Lotta Aids E Tossicodipendenza.

What drugs are being tested in NCT06806943?

Interventions in NCT06806943: avatar-based interactions.

What condition does NCT06806943 study?

NCT06806943 studies Substance Use Disorder (SUD).

Is NCT06806943 still recruiting?

NCT06806943 is currently completed. Last updated 4 February 2025.

Last reviewed 2025-02-04 · How we verify

NCT06806943

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

How Avatar Can Enhance Autobiographical Memory of Patients With Substance Use Disorder

Completed NA Last updated 4 February 2025

What this trial tests

NA trial testing avatar-based interactions in Substance Use Disorder (SUD) in 42 participants. Completed in 15 December 2024.

Timeline

1 July 2024

Primary endpoint
15 December 2024

15 December 2024

Quick facts

Lead sponsor	Le.L.A.T. Lega Lotta Aids E Tossicodipendenza
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	supportive care
Enrollment	42
Start date	1 July 2024
Primary completion	15 December 2024
Estimated completion	15 December 2024
Sites	1 location across Italy

Drugs / interventions tested

avatar-based interactions

Conditions studied

Substance Use Disorder (SUD) — all drugs for Substance Use Disorder (SUD) →

Sponsor

Le.L.A.T. Lega Lotta Aids E Tossicodipendenza

Who can join

18 and older, male only, with Substance Use Disorder (SUD). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this study is to investigate whether the use of artificial intelligence platforms can promote the retrieval of specific positive autobiographical memories.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Substance Use Disorder (SUD)

Currently open trials in the same condition.

NCT07278427 — Reducing Parental Substance Use and Enhancing Family Resilience Among Rural Families Through Ohio START · recruiting
NCT07503067 — Identifying Substance Use Consequences · recruiting
NCT06790641 — Pathways to Perinatal Mental Health Equity · NA · recruiting
NCT07433985 — California MEPS Hub · NA · recruiting
NCT07214467 — Individualized Adaptive Deep Brain Stimulation in Opioid Use Disorder · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06806943 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Le.L.A.T. Lega Lotta Aids E Tossicodipendenza
Last refreshed: 4 February 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06806943.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing